FDA approves first drug for tardive dyskinesia
On April 11, the U.S. Food and Drug Administration (FDA) approved Ingrezza (valbenazine) capsules to treat adults with tardive dyskinesia.…
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.